MYPS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Arcadia Biosciences RKDA Q3 2025 Profit Surges Past Wall Street Targets CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development ACAD Q1 2026 Earnings EPS Misses Estimates as Biotech Faces Profitability Headwinds PDS Q1 2026 Earnings EPS Falls Sharply Below Estimates Stock Edges Higher YSG Q4 2025 Earnings Positive EPS but Revenue Transparency Remains Limited